LNG-encapsulated Injectable PLGA Microspheres

Product Overview

Description: Levonorgestrel (LNG) microspheres encapsulated in PLGA are fabricated to achieve longer duration of hormone release. PLGA with 50:50 and 85:15 lactic acid to glycolic acid copolymer ratios have been studied. An estimated 5 months would be required to deplete the initial drug load with these copolymer ratios.

Updated date: July 21, 2016

Vertical Tabs

Status

Began discovery in: 2013

Download Product Report